• Home
  • Search Results
  • The inhibitory effect of Cordycepin on the proliferation of cisplatin-resistant A549 lung cancer cells.

The inhibitory effect of Cordycepin on the proliferation of cisplatin-resistant A549 lung cancer cells.

Biochemical and biophysical research communications (2018-03-03)
Seong Hyeok Cho, In-Cheol Kang
ABSTRACT

The goal of this study is to determine the anti-cancer mechanism of Cordycepin in A549 Cisplatin-Resistance (CR) lung cancer cells. Cordycepin inhibited the viability of A549CR cells in a dose-dependent manner. The cell inhibition was due to induction of apoptosis in the cells treated with Cordycepin by activation of caspase -3, -8 and -9 activities. The cell cycle analysis showed that accumulation of Sub G1 was observed in Cordycepin-treated with A549CR lung cancer cells. Based on the data of expression profile analysis of cell signaling proteins using IPS-FPAA, H-Ras was down-regulated in Cordycepin-treated A549CR cells. Collectively, anti-proliferative function of Cordycepin was due to stimulation of the cell apoptosis and the cell cycle arrest via caspases activation and down-regulation of H-Ras.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
SigmaSpin Sequencing Reaction Clean-Up, post-reaction clean-up columns

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.